ABBV vs NVO — Performance Comparison
Side-by-side percent change for AbbVie Inc. (ABBV), Novo Nordisk A/S (NVO) across every preset interval.
Over the past year, ABBV is up 15.55% versus NVO down 32.78% — ABBV ahead by 48.33%. Over the past 30 days, NVO is up 8.96% and ABBV is up 0.73%. ABBV trades at $209.94; NVO at $44.47.
| Ticker | Price | 1D | 3D | 7D | 30D | 90D | YTD | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV AbbVie Inc. | $209.94 | -0.40% ★ | +1.00% ★ | +4.16% ★ | +0.73% | -9.32% ★ | -8.12% ★ | -9.65% | +15.55% ★ | +46.51% ★ | +79.60% ★ |
| NVO Novo Nordisk A/S | $44.47 | -2.91% | -5.39% | -3.48% | +8.96% ★ | -10.30% | -12.61% | -7.86% ★ | -32.78% | -46.96% | +10.36% |
Want to zoom in?
Open the interactive Compare tool to overlay these tickers on a normalized chart, pin any two dates to see the exact return between them, and pick a custom interval.
Open in interactive CompareEach ticker's detail page
ABBVAbbVie Inc.
$209.94-0.40% today
NVONovo Nordisk A/S
$44.47-2.91% today